Cargando…

How to Successfully Develop Treatments for Early-Stage CKD: A Patient Perspective

Detalles Bibliográficos
Autor principal:	Friedman, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980613/ https://www.ncbi.nlm.nih.gov/pubmed/35391914 http://dx.doi.org/10.1016/j.xkme.2022.100441

Ejemplares similares

Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases
por: Damron, Kelli Collins, et al.
Publicado: (2022)

Interactions between CKD and MetS and the Development of CVD
por: Aihara, Ken-ichi, et al.
Publicado: (2011)

CKD in disadvantaged populations
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2015)

Cancer Treatment in CKD: Time to Move Beyond Renalism
por: Berger, Joseph Rossi, et al.
Publicado: (2023)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Low Turnover Bone Disease in Early CKD Stages
por: Barreto, Fellype Carvalho, et al.
Publicado: (2022)

A Pragmatic Low-Salt Diet in Patients with CKD
por: Bhandari, Sunil
Publicado: (2023)

Obesity Indices and the Risk of CKD
por: Tsuboi, Nobuo
Publicado: (2021)

Anticoagulation in CKD: Trials and Tribulations
por: Mohsen, Mai, et al.
Publicado: (2023)

Probiotics in CKD: waiting for the evidence
por: Campos, Letícia Fuganti
Publicado: (2023)

Increasing Sodium-Glucose Cotransporter 2 Inhibitor Use in CKD: Perspectives and Presentation of a Clinical Pathway
por: Nishi, Laura, et al.
Publicado: (2022)

Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients
por: Kanda, Eiichiro, et al.
Publicado: (2022)

Response to “Low Turnover Bone Disease in Early CKD Stages”
por: El-Husseini, Amr, et al.
Publicado: (2022)

Drug development: successes, problems and pitfalls—the industry perspective
por: Wein, Wolfgang
Publicado: (2016)

Qualitative approach to better understand the trajectory of patients with early and moderate stage CKD
por: Engberink, Agnes Oude, et al.
Publicado: (2022)

Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study
por: Chase, Herbert S, et al.
Publicado: (2014)

Eliminating Missed Opportunities for CKD Care
por: Kramer, Holly, et al.
Publicado: (2019)

Going micro in CKD-related cachexia
por: Wang, Xiaonan H, et al.
Publicado: (2020)

Testing Vitamin D Analogues for Vascular Calcification in Patients With CKD
por: Ramakrishnan, Madhuri, et al.
Publicado: (2020)

High mortality of CKD patients on hemodialysis with Covid-19 in Brazil
por: Pio-Abreu, Andrea, et al.
Publicado: (2020)

Electronic Health Record Portals and Patient-Centered Outcomes in CKD
por: Arzhan, Soraya, et al.
Publicado: (2021)

The Burden of Mental Health Conditions in Children With CKD
por: Kurzinski, Katherine L., et al.
Publicado: (2022)

Race, Social Class, and CKD: The Way Forward
por: Bruce, Marino A., et al.
Publicado: (2021)

Energy Metabolism in CKD: Running Low on Fuel
por: Saade, Marie Christelle, et al.
Publicado: (2023)

The Higher the CKD Stage, the Higher the Psychological Stress in Patients with CKD during COVID-19 Pandemic
por: Lee, Kyung-Mi, et al.
Publicado: (2022)

Palliative Care for Patients With Advanced CKD: Moving Beyond the Status Quo
por: Lu, Emily, et al.
Publicado: (2019)

Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus
por: Ba Aqeel, Sheeba, et al.
Publicado: (2019)

Dietary Habits, Vitamin and Mineral Supplements in Patients with Chronic Kidney Disease (CKD)
por: Messa, Piergiorgio
Publicado: (2020)

Cardiovascular disease in older women with CKD
por: Radley, Alice, et al.
Publicado: (2023)

Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved
por: Villalvazo, Priscila, et al.
Publicado: (2021)

Unmet needs for CKD care: from the general population to the CKD clinics—how many patients are we missing?
por: Torreggiani, Massimo, et al.
Publicado: (2021)

CKD-MBD in Brazil: the gap between reality and the recommended guidelines
por: Custódio, Melani Ribeiro
Publicado: (2018)

Quality of CKD Care: Don’t Take the Neighborhood Out of It Yet
por: Harding, Jessica L., et al.
Publicado: (2021)

Telehealth and Management Support for Hypertension in CKD: Time to Raise the Bar
por: Okpechi, Ikechi G., et al.
Publicado: (2023)

Shedding a light on sex disparity in clinical trials in CKD patients
por: Mallamaci, Francesca, et al.
Publicado: (2023)

Circadian Rhythm and CKD: Is Melatonin a Key Player or Bi-player?
por: Nagasawa, Yasuyuki, et al.
Publicado: (2019)

Magnesium and Cardiovascular Disease in CKD: The Mysteries of a Humble Divalent Cation
por: Kula, Alexander J., et al.
Publicado: (2021)

Treatment of Iron Deficiency Anemia in CKD and End-Stage Kidney Disease
por: Gutiérrez, Orlando M.
Publicado: (2021)

Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2017)

What should European nephrology do with the new CKD-EPI equation?
por: Gansevoort, Ron T, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g9v5ar31vvg336icpk7uhvtqqc